Search results
Pfizer shares the ADC data that convinced it to start a Phase 3 lung cancer trial
Endpoints News· 1 day agoWhen Pfizer laid out the ambitious vision for its new oncology division in February, it announced...
HILL TAX BRIEF: Wyden Blasts Pfizer on International Tax Shifts
Bloomberg Law· 3 days agoSenate Finance Committee Chair Ron Wyden (D-Ore.) is expanding his investigation into profit-shifting practices of pharmaceutical companies with a new letter to drug powerhouse Pfizer.
Invest $50k In This Stock To Become A Dividend Millionaire In 10 Years
Benzinga via Yahoo Finance· 11 hours agoWarren Buffett, the most successful dividend investor of all time, owes his success to a simple yet...
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
The Motley Fool via AOL· 17 hours ago(The long-term annual average return of the S&P 500 is around 10%.) If you're looking for very promising stocks that can help you build wealth in the years ahead, here are three to consider.
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days agoFEATURE Moderna and Pfizer are in talks with the federal government over a potential avian flu...
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
CNBC· 2 days agoPfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 3 days agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...
Pfizer expands cost cuts with new $1.5B target
BioPharma Dive via Yahoo Finance· 3 days agoThe company, which previously announced plans to trim $4 billion in spending by the end of 2024, aims to save another $1.5 billion over the next three...
Pfizer (PFE) Recently Broke Out Above the 200-Day Moving Average
Zacks via Yahoo Finance· 2 days agoFrom a technical perspective, Pfizer (PFE) is looking like an interesting pick, as it just reached a...
Is Pfizer Finally Seeing Light at the End of the Tunnel?
TheStreet.com· 2 days agoPharmaceutical giant Pfizer (PFE) has been a weak performer in the stock market. The shares are...